A stent fracture combined with a coronary artery aneurysm is a rare event. As these events can lead to a harmful outcome, such as the development of myocardial ischemia by in-stent restenosis or thrombosis, repeated coronary intervention may be required. We report a case of a stent fracture combined with a coronary artery aneurysm. The fracture was thought to have developed by mechanical stress produced from a change of regional wall motion after an anteroseptal myocardial infarction. As detected by the use of intravascular ultrasound, neither in-stent restenosis nor a thrombus in the fractured stent was present. A cardiac magnetic resonance image showed that no viable myocardium in the anteroseptal wall was present. Therefore, the patient underwent medical treatment without intervention of the fractured stent. 
Introduction
The use of drug-eluting stents (DES) has reduced in-stent restenosis by inhibiting neointimal hyperplasia. The use of DES has been applied widely as an effective interventional therapeutic modality in coronary artery disease. However, complications such as restenosis or a stent thrombosis remain in this era of using DES. Recently, stent fractures and coronary artery aneurysms after the implantation of a drug-eluting stent have emerged as novel complications as these occurrences may cause restenosis or a thrombosis. We report here a case of stent fracture combined with coronary aneurysm after percutaneous coronary intervention (PCI) with a drug-eluting stent.
Case
A 70 year-old woman was admitted to the hospital with effort angina. Coronary angiography revealed diffuse and significant stenosis in the proximal and mid portion of the left anterior descending artery (LAD) (Fig. 1A) . The LAD lesion was treated with two overlapping 3.5×23 mm and 3.0×33 mm sirolimuseluting stents (SES; Cypher ® , Cordis, Miami Lakes, FL USA). Final angiography showed the presence of welldeployed stents without residual stenosis or dissection. However, the big septal artery was jailed with thrombolysis in myocardial infarction (TIMI) 0 distal flow (Fig. 1B) . Although we attempted to wire the jailed artery, wiring failed as the artery was below the overlapping site and the lesion was tight. The day after the PCI, the level of a cardiac biomarker, the creatinine kinase MB fraction, increased to 114 ng/mL and echocardiography revealed akinetic regional wall motion abnormality at the anteroseptum from the mid to the apex. Sixteen months later, the patient suffered from resting chest discomfort again and underwent coronary angiography. There was complete stent fracture combined with a coronary artery aneurysm, but no significant in-stent restenosis ( Fig. 1C and D) . Intravascular ultrasound (IVUS) confirmed the discontinuation of the stent strut and an aneurysmal change (Fig. 2) . A cardiac magnetic resonance image (MRI) showed the presence of myocardial thinning with transmural delayed hyperenhancement and akinetic motion on the anteroseptal segement (Fig. 3) . We concluded that the symptom was not associated with the stent fracture or the coronary artery aneurysm as previously placed stents were patent and the anteroseptal myocardial wall was not viable. Therefore, we decided to continue clinical surveillance. Six months later, the patient is receiving follow-up and has been without symptoms.
Discussion
DES have been used widely for the effectiveness about restenosis. However, recently a few cases concerning the fracture of DES and stent related aneurysms have been reported. These occurrences may be considerable complications because of the association with restenosis or stent thrombosis. [1] [2] [3] [4] [5] [6] Although the cause and pathophysiology of both complications are not known, most cases have occurred when there are higher radial forces, usage of longer stents or the use of overlapping stents. 7) These events typically occur in a hypermobile and tortuous vessel, especially the right coronary artery. 8) Overexpansion of the stent can be another risk factor as it may weaken struts and promote the fracture. Coronary artery aneurysms might result from local hypersensitivity vasculitis in response to the polymer or coating drug on the DES. 9) In our case, the big septal artery was occluded totally after sirolimus-eluting stent implantation, resulting in akinetic motion on the anteroseptal wall. The change of regional wall motion might have developed a new hinge in the overlapping long stents during the cardiac cycle. Thus, mechanical stress on overlapping stents could provoke the fracture of the sirolimus-eluting stents.
The coronary artery aneurysm of this case was observed at a fractured segment in the overlapping stents. Mechanical irritation of fractured struts may have caused aneurysmal dilation of the coronary vessel, and a local hypersensitivity reaction may be attributable to the coronary aneurysm.
Unfortunately, the natural history of DES fracture and coronary artery aneurysm has not yet been de- fined. Moreover, the best treatment for the problems is unknown. In our case, there was restenosis or thrombosis was not present at the fractured stent. Cardiac MRI was performed to formulate the management plan because the anteroseptal wall was already akinetic as determined by previous echocardiography. Considering the absence of a viable portion in the anteroseptal wall as seen on cardiac MRI and the relative small sized coronary aneurysm, we decided to continue clinical follow-up instead of performing an interventional procedure on the LAD lesion. Studies about DES fractures and coronary aneurysms are still very limited, but physicians should be concerned as these complications can be associated with restenosis or a thrombosis. A further investigation is needed to define the clinical significance of a DES fracture and coronary artery aneurysm. 
